Mirikizumab, Tirzepatide, to match Tirzepatide, Tirzepatide, Tirzepatide, Mirikizumab, Tirzepatide, Tirzepatide, Tirzepatide
I6T-MC-AMCD
Phase 3 small_molecule active
Quick answer
Mirikizumab, Tirzepatide, to match Tirzepatide, Tirzepatide, Tirzepatide, Mirikizumab, Tirzepatide, Tirzepatide, Tirzepatide for Obesity or Overweight, Ulcerative Colitis is a Phase 3 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Obesity or Overweight, Ulcerative Colitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active